Abstract:Introduction: Pancreatic cancer is difficult to diagnose due to its asymptomatic presentation at early stages. Therefore, there is an unmet need for non-invasive imaging markers that can help identify the aggressive pancreatic lesions at an early time point. One of the most promising imaging biomarkers is the conversion of hyperpolarized (HP) pyruvate to lactate1-3. With HP metabolic imaging, the conversion will be monitored among different premalignant models at different timepoints as well as tested against pancreatitis, a known confounder of pancreatic cancer in the clinic. Methods: HP [1-13C]pyruvate Magnetic Resonance Spectroscopy (MRS) was employed to study the metabolic processes in tamoxifen inducible genetically engineered mouse models (P48CreERT2;LSL-KrasG12D(iKC)) with pre-invasive pancreatic intraepithelial neoplasia (PanIN) precursor lesions, invasive pancreatic cancer model (P48CreERT2;LSL-KrasG12D; LSL-p53R172H (iKPC)) and control animals (P48CreERT2 (iC)) at 7T Bruker MRI scanner. These mice were imaged before tamoxifen induction at 10-, 20-, and 30-weeks post induction. For the pancreatitis model, iC and iKC mice they were treated with caerulein for three weeks, 7 weeks after tamoxifen induction. The pancreatitis mice were imaged 24 hours after the last caerulein injection. Results/Discussion: HP lactate-to-pyruvate ratio is increased in the cancer models compared to the control model. In the iKPC mouse model, at the 20-week post induction imaging there was a significant increase of the lactate-to-pyruvate ratio compared to the 10-weektime point after induction. The 20-week iKPC time point ratio compared to the iKC and control mouse models was significantly higher, indicating the aggressive nature of the disease. Even in the iKC model there is a slight increase of the lactate-to-pyruvate ratio at 20-weeks post induction compared to both previous time points, pre-induction and 10-week. No change in the lactate-to-pyruvate ratio was not observed with the pancreatitis phenotype. In the future, we plan on imaging at earlier timepoints or at smaller intervals in the iKPC model, to observe the exact moment the metabolism switches to lactate. Conclusion: Our data demonstrates that the metabolic flux to lactate is only increasing in the premalignant models of pancreatic cancer but not in the pancreatitis model, suggesting that the differentiation between early pancreatic cancer and pancreatitis can be achieved by hyperpolarized metabolic imaging. We are currently in the process of translating this in a clinical trial at MD Anderson Cancer Center. Citation Format: Paytience L. Smith, José S. Enriquez, Rian Howell, Olivereen Le Roux, Shivanand Pudakalakatti, Prasanta Dutta, Florencia Mcallister, Pratip Bhattacharya. Early detection of pancreatic cancer by hyperpolarized magnetic resonance [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 6165.

Real‐Time Metabolic Magnetic Resonance Spectroscopy of Pancreatic and Colon Cancer Tumor‐Xenografts with Parahydrogen Hyperpolarized 1‐13C Pyruvate‐d3

In Vivo Molecular Imaging of Breast Cancer Metabolic Heterogeneity Using [1-13C]Pyruvate-d3 Hyperpolarized By Reversible Exchange With Parahydrogen

Hyperpolarized 13C-pyruvate MRI detects real-time metabolic flux in prostate cancer metastases to bone and liver: a clinical feasibility study

Direct Arterial Injection of Hyperpolarized 13c‐labeled Substrates into Rat Tumors for Rapid MR Detection of Metabolism with Minimal Substrate Dilution

Hyperpolarized 13 C MRI : State of the Art and Future Directions

Enhancing Cancer Diagnosis with Real-Time Feedback: Tumor Metabolism through Hyperpolarized 1-13C Pyruvate MRSI

Hyperpolarized 13C Metabolic MRI of Patients with Pancreatic Ductal Adenocarcinoma

Current Methods for Hyperpolarized [1-13C]pyruvate MRI Human Studies

In vivo Metabolic Sensing of Hyperpolarized [1‐13 C]Pyruvate in Mice Using a Recyclable Perfluorinated Iridium Signal Amplification by Reversible Exchange Catalyst

Current methods for hyperpolarized [1‐13C]pyruvate MRI human studies

13C-labeled biochemical probes for the study of cancer metabolism with dynamic nuclear polarization-enhanced magnetic resonance imaging

Parahydrogen-enhanced pH measurements using [1- 13 C]bicarbonate derived from non-enzymatic decarboxylation of [1- 13 C]pyruvate-d 3

13C MRI of hyperpolarized pyruvate at 120 μT

Deuterium MRSI characterizations of glucose metabolism in orthotopic pancreatic cancer mouse models

The use of hyperpolarised 13C-MRI in clinical body imaging to probe cancer metabolism

Carbon-13 Radiofrequency Amplification by Stimulated Emission of Radiation of the Hyperpolarized Ketone and Hemiketal Forms of Allyl [1- 13 C]Pyruvate

Radio-Frequency Sweeps at μT Fields for Parahydrogen-Induced Polarization of Biomolecules

In Vivo Mrsi Of Hyperpolarized [1-C-13]Pyruvate Metabolism In Rat Hepatocellular Carcinoma

Abstract 6165: Early detection of pancreatic cancer by hyperpolarized magnetic resonance

Hyperpolarized [2- 13 C]Pyruvate MR Molecular Imaging with Whole Brain Coverage

Translation of Carbon-13 EPI for hyperpolarized MR molecular imaging of prostate and brain cancer patients